Ascites-Free In-Vitro Technology for Monoclonal Antibody Production
New NIH Guidelines Encourage Use of Ascites-Free In-Vitro Technology for Monoclonal Antibody Production
The official NIH position is that the government will continue to promote alternatives whenever possible, and investigators will still be required to justify the use of in vivo antibody production on a case-by-case basis, as stipulated by the Public Health Service Policy There is evidence that the mouse ascites method of monoclonal antibody production causes discomfort, distress, or pain. Practical in vitro methods exist which can replace the ascites method in many experimental applications without compromising the aims of the study. (OPRR Report, number 98-01, Animal Welfare) IACUCs are expected to critically evaluate the proposed use of the mouse ascites method.Prior to approval of proposals which include the mouse ascites method, IACUCs must determine that (i) the proposed use is scientifically justified, (ii) methods that avoid or minimize discomfort, distress, and pain (including in vitro methods) have been considered, and (iii) the latter have been found unsuitable. Fulfillment of this three-part IACUC responsibility, with appropriate documentation, is considered central to an institution’s compliance with its Animal Welfare Assurance and the PHS Policy. (OPRR Report, number 98-01, Animal Welfare).
Antibody Solutions offers cutting-edge cost-effective solutions for ascites-free in vitro production of monoclonal antibodies at all scales!. Please Contact us with your specific antibody production needs.
Tel: 888-843-1069 Fax: 650-938-4390 E-mail: email@example.com